MedPath

MAGNESIUM SULFATE INJ 50%

MAGNESIUM SULFATE INJ 50%

Discontinued
DIN Number

01944932

Drug Class

Human

Market Date

Dec 31, 1992

Company
HC

lyphomed, division of fujisawa canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01944932
AIG Number0105356002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XA05 MAGNESIUM SULPHATE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular ,  Intravenous
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

MAGNESIUM SULFATEActive
Strength: 500 MG / ML
Monograph: MAGNESIUM SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.